• Key PBC Studies From AASLD 2024

  • Jan 7 2025
  • Length: 20 mins
  • Podcast

Key PBC Studies From AASLD 2024

Listen for free

View show details

  • Summary

  • In this episode, Sonal Kumar, MD, MPH, discusses key findings from primary biliary cholangitis (PBC) studies presented at AASLD 2024, including:

    • ELATIVE, a phase III trial of elafibranor for PBC
    • RESPONSE, a phase III trial of seladelpar for PBC
    • ASSURE, another phase III trial of seladelpar for PBC

    Presenter:
    Sonal Kumar, MD, MPH
    Director, Clinical Gastroenterology and Hepatology
    Assistant Professor of Medicine
    Weill Cornell Medical College
    New York, New York

    Link to full program:
    https://bit.ly/41tvSDu

    Get access to all of our new podcasts by subscribing to the CCO Infectious Disease Podcast on Apple Podcasts, Google Podcasts, or Spotify.
    Show More Show Less
Show More Show Less

What listeners say about Key PBC Studies From AASLD 2024

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.co.uk reviews

Amazon reviews
No Reviews are Available